Illinois 93rd Regular Session Status: Enacted

SB 2253 — NAPRAPATHIC PRACTICE-TECH

Last action — Public Act . . . . . . . . . 93-1075

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed House
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced January 15, 2004. Enacted.

Prognosis

Likely to advance 70% · moderate confidence

Where this bill stands today.

Odds of enactment

High

How often bills like it became law.

  • Enacted

    Current position in the legislative process.

  • 1 sponsor

    0 primary, 1 co-sponsors signed on.

  • Cleared a recorded vote

    Passed 4 recorded votes so far.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

Amends the Naprapathic Practice Act. Makes a technical change to a Section concerning the necessity of a license.

Bill Text

What changed in the latest version

194 added · 10 removed

Plain-language change summary

The amendment to SB 2253 modifies the Pharmacy Practice Act by updating the definition of what constitutes a pharmacy or drugstore. This change clarifies that any establishment providing pharmaceutical care and displaying certain relevant signs, such as "Pharmacy" or "Prescription," is included under this act. These updates are important because they ensure that all businesses offering medication and pharmaceutical services are properly regulated, which helps protect public health and safety.

→
Previous
Latest
SB2253 Engrossed LRB093 15878 RCE 41495 b AN ACT concerning professional regulation.
SB2253 Enrolled LRB093 15878 RCE 41495 b AN ACT concerning professional regulation.
The Naprapathic Practice Act is amended by changing Section 20 as follows:
The Pharmacy Practice Act of 1987 is amended by changing Section 3 as follows:
(225 ILCS 63/20) (Section scheduled to be repealed on January 1, 2013) Sec.
(225 ILCS 85/3) (from Ch.
20.
111, par.
Necessity of license.
4123) (Section scheduled to be repealed on January 1, 2008) Sec.
No person shall practice or attempt to practice naprapathy as defined in this Act without possessing a valid license as a naprapath issued by the Department.
3.
Definitions.
For the purpose of this Act, except where otherwise limited therein:
(a) "Pharmacy" or "drugstore" means and includes every store, shop, pharmacy department, or other place where pharmaceutical care is provided by a pharmacist (1) where drugs, medicines, or poisons are dispensed, sold or offered for sale at retail, or displayed for sale at retail;
or (2) where prescriptions of physicians, dentists, veterinarians, podiatrists, or therapeutically certified optometrists, within the limits of their licenses, are compounded, filled, or dispensed;
or (3) which has upon it or displayed within it, or affixed to or used in connection with it, a sign bearing the word or words "Pharmacist", "Druggist", "Pharmacy", "Pharmaceutical Care", "Apothecary", "Drugstore", "Medicine Store", "Prescriptions", "Drugs", "Medicines", or any word or words of similar or like import, either in the English language or any other language;
or (4) where the characteristic prescription sign (Rx) or similar design is exhibited;
or (5) any store, or shop, or other place with respect to which any of the above words, objects, signs or designs are used in any advertisement.
(b) "Drugs" means and includes (l) articles recognized in the official United States Pharmacopoeia/National Formulary (USP/NF), or any supplement thereto and being intended for and having for their main use the diagnosis, cure, mitigation, SB2253 Enrolled - 2 - LRB093 15878 RCE 41495 b treatment or prevention of disease in man or other animals, as approved by the United States Food and Drug Administration, but does not include devices or their components, parts, or accessories;
and (2) all other articles intended for and having for their main use the diagnosis, cure, mitigation, treatment or prevention of disease in man or other animals, as approved by the United States Food and Drug Administration, but does not include devices or their components, parts, or accessories;
and (3) articles (other than food) having for their main use and intended to affect the structure or any function of the body of man or other animals;
and (4) articles having for their main use and intended for use as a component or any articles specified in clause (l), (2) or (3);
but does not include devices or their components, parts or accessories.
(c) "Medicines" means and includes all drugs intended for human or veterinary use approved by the United States Food and Drug Administration.
(d) "Practice of pharmacy" means the provision of pharmaceutical care to patients as determined by the pharmacist’s professional judgment in the following areas, which may include but are not limited to (1) patient counseling, (2) interpretation and assisting in the monitoring of appropriate drug use and prospective drug utilization review, (3) providing information on the therapeutic values, reactions, drug interactions, side effects, uses, selection of medications and medical devices, and outcome of drug therapy, (4) participation in drug selection, drug monitoring, drug utilization review, evaluation, administration, interpretation, application of pharmacokinetic and laboratory data to design safe and effective drug regimens, (5) drug research (clinical and scientific), and (6) compounding and dispensing of drugs and medical devices.
(e) "Prescription" means and includes any written, oral, facsimile, or electronically transmitted order for drugs or medical devices, issued by a physician licensed to practice medicine in all its branches, dentist, veterinarian, or SB2253 Enrolled - 3 - LRB093 15878 RCE 41495 b podiatrist, or therapeutically certified optometrist, within the limits of their licenses, by a physician assistant in accordance with subsection (f) of Section 4, or by an advanced practice nurse in accordance with subsection (g) of Section 4, containing the following:
(l) name of the patient;
(2) date when prescription was issued;
(3) name and strength of drug or description of the medical device prescribed;
and (4) quantity, (5) directions for use, (6) prescriber’s name, address and signature, and (7) DEA number where required, for controlled substances.
DEA numbers shall not be required on inpatient drug orders.
(f) "Person" means and includes a natural person, copartnership, association, corporation, government entity, or any other legal entity.
(g) "Department" means the Department of Professional Regulation.
(h) "Board of Pharmacy" or "Board" means the State Board of Pharmacy of the Department of Professional Regulation.
(i) "Director" means the Director of Professional Regulation.
(j) "Drug product selection" means the interchange for a prescribed pharmaceutical product in accordance with Section 25 of this Act and Section 3.14 of the Illinois Food, Drug and Cosmetic Act.
(k) "Inpatient drug order" means an order issued by an authorized prescriber for a resident or patient of a facility licensed under the Nursing Home Care Act or the Hospital Licensing Act, or "An Act in relation to the founding and operation of the University of Illinois Hospital and the conduct of University of Illinois health care programs", approved July 3, 1931, as amended, or a facility which is operated by the Department of Human Services (as successor to the Department of Mental Health and Developmental Disabilities) or the Department of Corrections.
(k-5) "Pharmacist" means an individual health care professional and provider currently licensed by this State to SB2253 Enrolled - 4 - LRB093 15878 RCE 41495 b engage in the practice of pharmacy.
(l) "Pharmacist in charge" means the licensed pharmacist whose name appears on a pharmacy license and who is responsible for all aspects of the operation related to the practice of pharmacy.
(m) "Dispense" means the delivery of drugs and medical devices, in accordance with applicable State and federal laws and regulations, to the patient or the patient’s representative authorized to receive these products, including the preparation, compounding, packaging, and labeling necessary for delivery, computer entry, and verification of medication orders and prescriptions, and any recommending or advising concerning the contents and therapeutic values and uses thereof.
"Dispense" does not mean the physical delivery to a patient or a patient’s representative in a home or institution by a designee of a pharmacist or by common carrier.
"Dispense" also does not mean the physical delivery of a drug or medical device to a patient or patient’s representative by a pharmacist’s designee within a pharmacy or drugstore while the pharmacist is on duty and the pharmacy is open.
(n) "Mail-order pharmacy" means a pharmacy that is located in a state of the United States, other than Illinois, that delivers, dispenses or distributes, through the United States Postal Service or other common carrier, to Illinois residents, any substance which requires a prescription.
(o) "Compounding" means the preparation, mixing, assembling, packaging, or labeling of a drug or medical device:
(1) as the result of a practitioner’s prescription drug order or initiative that is dispensed pursuant to a prescription in the course of professional practice;
Show all 59 changed rows (19 more)
Previous
Latest
or (2) for the purpose of, or incident to, research, teaching, or chemical analysis;
or (3) in anticipation of prescription drug orders based on routine, regularly observed prescribing patterns.
(p) "Confidential information" means information, maintained by the pharmacist in the patient’s records, released only (i) to the patient or, as the patient directs, to other SB2253 Enrolled - 5 - LRB093 15878 RCE 41495 b practitioners and other pharmacists or (ii) to any other person authorized by law to receive the information.
(q) "Prospective drug review" or "drug utilization evaluation" means a screening for potential drug therapy problems due to therapeutic duplication, drug-disease contraindications, drug-drug interactions (including serious interactions with nonprescription or over-the-counter drugs), drug-food interactions, incorrect drug dosage or duration of drug treatment, drug-allergy interactions, and clinical abuse or misuse.
(r) "Patient counseling" means the communication between a pharmacist or a student pharmacist under the direct supervision of a pharmacist and a patient or the patient’s representative about the patient’s medication or device for the purpose of optimizing proper use of prescription medications or devices.
The offer to counsel by the pharmacist or the pharmacist’s designee, and subsequent patient counseling by the pharmacist or student pharmacist, shall be made in a face-to-face communication with the patient or patient’s representative unless, in the professional judgment of the pharmacist, a face-to-face communication is deemed inappropriate or unnecessary.
In that instance, the offer to counsel or patient counseling may be made in a written communication, by telephone, or in a manner determined by the pharmacist to be appropriate.
(s) "Patient profiles" or "patient drug therapy record" means the obtaining, recording, and maintenance of patient prescription information, including prescriptions for controlled substances, and personal information.
(t) "Pharmaceutical care" includes, but is not limited to, the act of monitoring drug use and other patient care services intended to achieve outcomes that improve the patient’s quality of life but shall not include the sale of over-the-counter drugs by a seller of goods and services who does not dispense prescription drugs.
(u) "Medical device" means an instrument, apparatus, SB2253 Enrolled - 6 - LRB093 15878 RCE 41495 b implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component part or accessory, required under federal law to bear the label "Caution:
Federal law requires dispensing by or on the order of a physician".
A seller of goods and services who, only for the purpose of retail sales, compounds, sells, rents, or leases medical devices shall not, by reasons thereof, be required to be a licensed pharmacy.
(v) "Unique identifier" means an electronic signature, handwritten signature or initials, thumb print, or other acceptable individual biometric or electronic identification process as approved by the Department.
87-1231.)
92-880, eff.
1-1-04;
93-571, eff.
8-20-03.) Section 99.
Effective date.
This Act takes effect upon becoming law.
⬇ Download PDF
View plain text versions (3)

How this bill changes current law

1 change Share ↗

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

The bill updates the definitions in the Pharmacy Practice Act of 1987.

  • 225 ILCS 85/3

    (k-5) "Pharmacist" means an individual health care professional and provider currently licensed by this State to engage in the practice of pharmacy.

    This change defines 'Pharmacist' explicitly to clarify who is authorized to practice pharmacy.

Action History

  1. Public Act . . . . . . . . . 93-1075

  2. Effective Date January 18, 2005

  3. Governor Approved

  4. Sent to the Governor

  5. Passed Both Houses

  6. House Floor Amendment No. 2 Senate Concurs 058-000-001

  7. House Committee Amendment No. 1 Senate Concurs 058-000-001

  8. House Floor Amendment No. 2 Motion to Concur Be Adopted Licensed Activities; 009-000-000

  9. House Committee Amendment No. 1 Motion to Concur Be Adopted Licensed Activities; 009-000-000

  10. House Floor Amendment No. 2 Motion to Concur Rules Referred to Licensed Activities

  11. House Committee Amendment No. 1 Motion to Concur Rules Referred to Licensed Activities

  12. Placed on Calendar Order of Concurrence House Amendment(s) 01, 02 -November 18, 2004

  13. Approved for Consideration Rules

  14. House Floor Amendment No. 2 Motion to Concur-Pursuant to Senate Rule 3-9(b)-Referred to Rules.

  15. House Committee Amendment No. 1 Motion to Concur-Pursuant to Senate Rule 3-9(b)-Referred to Rules.

  16. Pursuant to Senate Rule 3-9(b) / Referred to Rules

  17. House Floor Amendment No. 2 Motion to Concur Be Adopted Licensed Activities; 009-000-000

  18. House Committee Amendment No. 1 Motion to Concur Be Adopted Licensed Activities; 009-000-000

  19. Sponsor Removed Sen. Mattie Hunter

  20. House Floor Amendment No. 2 Motion to Concur Rules Referred to Licensed Activities

  21. House Committee Amendment No. 1 Motion to Concur Rules Referred to Licensed Activities

  22. House Floor Amendment No. 2 Motion to Concur Referred to Rules

  23. House Floor Amendment No. 2 Motion to Concur Filed with Secretary Sen. Deanna Demuzio

  24. House Committee Amendment No. 1 Motion to Concur Referred to Rules

  25. House Committee Amendment No. 1 Motion to Concur Filed with Secretary Sen. Deanna Demuzio

  26. Chief Sponsor Changed to Sen. Deanna Demuzio

  27. Placed on Calendar Order of Concurrence House Amendment(s) 01,02 - May 27, 2004

  28. Secretary's Desk - Concurrence House Amendment(s) 01,02

  29. Third Reading - Short Debate - Passed 114-000-000

  30. Placed on Calendar Order of 3rd Reading - Short Debate

  31. House Floor Amendment No. 2 Adopted by Voice Vote

  32. Second Reading - Short Debate

  33. House Floor Amendment No. 2 Recommends Be Adopted Rules Committee; 004-000-000

  34. House Floor Amendment No. 2 Referred to Rules Committee

  35. House Floor Amendment No. 2 Filed with Clerk by Rep. Angelo Saviano

  36. Placed on Calendar 2nd Reading - Short Debate

  37. Do Pass as Amended / Short Debate Registration and Regulation Committee; 014-000-000

  38. House Committee Amendment No. 1 Adopted in Registration and Regulation Committee; by Voice Vote

  39. House Committee Amendment No. 1 Filed with Clerk by Registration and Regulation Committee

  40. Committee/3rd Reading Deadline Extended-Rule 9(b) May 31, 2004

  41. Assigned to Registration and Regulation Committee

  42. Rule 19(a) / Re-referred to Rules Committee

  43. Assigned to Executive Committee

  44. Referred to Rules Committee

  45. First Reading

  46. Chief House Sponsor Rep. Angelo Saviano

  47. Placed on Calendar Order of First Reading

  48. Arrived in House

  49. Added as Chief Co-Sponsor Sen. Mattie Hunter

  50. Third Reading - Passed; 033-025-000

  51. Placed on Calendar Order of 3rd Reading March 25, 2004

  52. Second Reading

  53. Placed on Calendar Order of 2nd Reading March 2, 2004

  54. Do Pass State Government; 005-004-000

  55. Assigned to State Government

  56. Referred to Rules

  57. First Reading

  58. Filed with Secretary by Sen. Emil Jones, Jr.

Sponsors

  • Deanna Demuzio · Cosponsor

Sponsorship breakdown

Export CSV (upgrade) →

0 sponsors · 1 co-sponsors · 182 not signed on · 1 voted No

Sponsors (0)

None.

Co-sponsors (1)

  • Deanna Demuzio

Not signed on (182)

182 members have not signed on to this bill.

Show all 182 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Concurrence

Passed 58 Yea · 0 Nay · 1 Other
Party YeaNayPresentNot Voting
Unaffiliated 50001
Democrat 7000
Republican 1000
Total 58001
% of votes cast 98%0%0%2%
How each member voted (59)
Member Party Vote
Sandoval — Yea
Silverstein — Yea
Soden — Yea
Maloney — Yea
Althoff — Yea
Martinez — Yea
Bomke — Yea
Burzynski — Yea
Forby — Yea
Haine — Yea
Halvorson — Yea
Lauzen — Yea
Munoz — Yea
Link — Yea
Luechtefeld — Yea
Meeks — Yea
Brady — Yea
Sullivan, D. — Yea
Petka — Yea
Sullivan, J. — Yea
Radogno — Yea
Schoenberg — Yea
Shadid — Yea
Jacobs — Yea
Sieben — Yea
Jones, J. — Yea
Jones, W. — Yea
Cullerton — Yea
Trotter — Yea
Demuzio — Yea
Viverito — Yea
Winkel — Yea
Watson — Not Voting
Wojcik — Yea
Clayborne — Yea
Cronin — Yea
Crotty — Yea
DeLeo — Yea
Dillard — Yea
Garrett — Yea
Geo-Karis — Yea
Hendon — Yea
Peterson — Yea
Raoul — Yea
Rauschenberger — Yea
Righter — Yea
Risinger — Yea
Ronen — Yea
Roskam — Yea
Rutherford — Yea
del Valle — Yea
Don Harmon Democrat Yea
Emanuel "Chris" Welch Democrat Yea
Emil Jones, III Democrat Yea
Kimberly A. Lightford Democrat Yea
Lakesia Collins Democrat Yea
Lawrence "Larry" Walsh, Jr. Democrat Yea
Mattie Hunter Democrat Yea
Dave Syverson Republican Yea

Official roll call →

Concurrence, Amendment 2

Passed 58 Yea · 0 Nay · 1 Other
Party YeaNayPresentNot Voting
Unaffiliated 50001
Democrat 7000
Republican 1000
Total 58001
% of votes cast 98%0%0%2%
How each member voted (59)
Member Party Vote
Sandoval — Yea
Sieben — Yea
Silverstein — Yea
Soden — Yea
Link — Yea
Althoff — Yea
Martinez — Yea
Bomke — Yea
Burzynski — Yea
Halvorson — Yea
Meeks — Yea
Munoz — Yea
Brady — Yea
Sullivan, D. — Yea
Petka — Yea
Geo-Karis — Yea
Haine — Yea
Sullivan, J. — Yea
Lauzen — Yea
Jacobs — Yea
Jones, J. — Yea
Jones, W. — Yea
Cullerton — Yea
Luechtefeld — Yea
Demuzio — Yea
Maloney — Yea
Watson — Not Voting
Schoenberg — Yea
Shadid — Yea
Trotter — Yea
Viverito — Yea
Winkel — Yea
Wojcik — Yea
Clayborne — Yea
Cronin — Yea
Crotty — Yea
DeLeo — Yea
Dillard — Yea
Forby — Yea
Garrett — Yea
Hendon — Yea
Peterson — Yea
Radogno — Yea
Raoul — Yea
Rauschenberger — Yea
Righter — Yea
Risinger — Yea
Ronen — Yea
Roskam — Yea
Rutherford — Yea
del Valle — Yea
Don Harmon Democrat Yea
Emanuel "Chris" Welch Democrat Yea
Emil Jones, III Democrat Yea
Kimberly A. Lightford Democrat Yea
Lakesia Collins Democrat Yea
Lawrence "Larry" Walsh, Jr. Democrat Yea
Mattie Hunter Democrat Yea
Dave Syverson Republican Yea

Official roll call →

Third Reading

Passed 114 Yea · 0 Nay · 4 Other
Party YeaNayPresentNot Voting
Unaffiliated 102004
Democrat 9000
Republican 3000
Total 114004
% of votes cast 97%0%0%3%
How each member voted (118)
Member Party Vote
Saviano — Yea
Schmitz — Yea
Scully — Yea
Slone — Yea
Sommer — Yea
Soto — Yea
Lindner — Yea
Krause — Yea
Acevedo — Yea
Aguilar — Yea
Mathias — Yea
Bassi — Yea
Beaubien — Yea
Bellock — Yea
Berrios — Yea
Biggins — Yea
Black — Yea
Boland — Yea
May — Yea
Bost — Yea
Brauer — Yea
Brosnahan — Yea
Capparelli — Yea
McAuliffe — Yea
Moffitt — Yea
Daniels — Yea
Mulligan — Yea
Eddy — Yea
Hamos — Yea
Holbrook — Yea
Jefferson — Yea
Pankau — Yea
Kurtz — Yea
Lang — Yea
Leitch — Yea
Phelps — Yea
Pihos — Yea
Bailey — Yea
Lyons, Eileen — Yea
Reitz — Yea
Lyons, Joseph — Yea
Dugan — Yea
Dunkin — Yea
Dunn — Yea
Flider — Yea
Mautino — Yea
McCarthy — Yea
McKeon — Yea
Mendoza — Yea
Meyer — Yea
Millner — Yea
Molaro — Yea
Morrow — Yea
Munson — Yea
McGuire — Yea
Myers — Yea
Bradley, John — Yea
Nekritz — Yea
Bradley, Richard — Yea
Tenhouse — Yea
Brady — Yea
Turner — Yea
Verschoore — Yea
Wait — Yea
Washington — Yea
Winters — Yea
Burke — Yea
Mitchell, Bill — Yea
Hannig — Yea
Sullivan — Yea
Mitchell, Jerry — Yea
Watson — Yea
Jones — Yea
Churchill — Yea
Colvin — Yea
Coulson — Yea
Cross — Yea
Currie — Yea
Flowers — Yea
Franks — Yea
Fritchey — Yea
Froehlich — Yea
Giles — Yea
Gordon — Yea
Graham — Yea
Granberg — Yea
Grunloh — Yea
Hassert — Yea
Hultgren — Yea
Jakobsson — Yea
Davis, Monique — Yea
Howard — Not Voting
Davis, Steve — Not Voting
Madigan — Yea
Osmond — Yea
Osterman — Yea
Parke — Not Voting
Cultra — Not Voting
Kosel — Yea
Yarbrough — Yea
Younge — Yea
Poe — Yea
Pritchard — Yea
Ryg — Yea
Sacia — Yea
Chapa LaVia — Yea
Eva-Dina Delgado Democrat Yea
Jay Hoffman Democrat Yea
Lakesia Collins Democrat Yea
Michael J. Kelly Democrat Yea
Nicholas K. Smith Democrat Yea
Patrick J. Joyce Democrat Yea
Robert "Bob" Rita Democrat Yea
Sara Feigenholtz Democrat Yea
William "Will" Davis Democrat Yea
Brad Stephens Republican Yea
Chapin Rose Republican Yea
Chris Miller Republican Yea

Official roll call →

Third Reading

Passed 33 Yea · 25 Nay · 1 Other
Party YeaNayPresentNot Voting
Unaffiliated 262401
Democrat 7000
Republican 0100
Total 332501
% of votes cast 56%42%0%2%
How each member voted (59)
Member Party Vote
Sandoval — Yea
Silverstein — Yea
Viverito — Yea
Lauzen — Nay
Link — Yea
Luechtefeld — Nay
Althoff — Nay
Martinez — Yea
Bomke — Nay
Burzynski — Nay
Clayborne — Yea
Cronin — Yea
Haine — Yea
Halvorson — Yea
Meeks — Yea
Obama — Yea
Munoz — Yea
Trotter — Yea
Jacobs — Yea
Cullerton — Yea
Crotty — Yea
DeLeo — Yea
Geo-Karis — Yea
Hendon — Yea
Maloney — Yea
Brady — Nay
Sullivan, D. — Nay
Sullivan, J. — Nay
Petka — Nay
Jones, J. — Nay
Jones, W. — Nay
Watson — Nay
Demuzio — Not Voting
Peterson — Nay
Schoenberg — Yea
Shadid — Yea
Sieben — Nay
Soden — Nay
Winkel — Nay
Dillard — Yea
Forby — Nay
Garrett — Yea
Wojcik — Nay
Radogno — Nay
Rauschenberger — Nay
Righter — Nay
Risinger — Nay
Ronen — Yea
Roskam — Nay
Rutherford — Nay
del Valle — Yea
Don Harmon Democrat Yea
Emanuel "Chris" Welch Democrat Yea
Emil Jones, III Democrat Yea
Kimberly A. Lightford Democrat Yea
Lakesia Collins Democrat Yea
Lawrence "Larry" Walsh, Jr. Democrat Yea
Mattie Hunter Democrat Yea
Dave Syverson Republican Nay

Official roll call →

Subjects

healthcare technology
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 2253 do?
Amends the Naprapathic Practice Act. Makes a technical change to a Section concerning the necessity of a license.
Who sponsors SB 2253?
SB 2253 is sponsored by Deanna Demuzio.
What is the current status of SB 2253?
This bill has been enacted into law. Introduced January 15, 2004. Enacted.
Where can I track SB 2253?
Track SB 2253 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 2253

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 2253

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →